After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success.
Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success.
Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach on April 19 for a full day of networking and education.
Irwin Natural’s (OTCQB: IWINF) Irwin Naturals Cannabis, Inc., entered into a licensing agreement with California-based The Hive Laboratory, LLC, which will produce and distribute some of Irwin Naturals’ formulas, such as Power to Sleep, which is augmented with THC.
With the goal of becoming the world’s largest chain of psychedelic mental health clinics, Irwin Naturals Inc. (OTCQB: IWINF) announced the acquisition of five ketamine treatment clinics in Florida and a partnership contract with two clinics in Mexico.